Mark Foletta
2018
In 2018, Mark Foletta earned a total compensation of $1.2M as Executive Vice President and Chief Financial Officer at Forte Biosciences, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,688 |
|---|---|
| Option Awards | $701,054 |
| Salary | $378,981 |
| Other | $426 |
| Total | $1,241,149 |
Foletta received $701.1K in option awards, accounting for 56% of the total pay in 2018.
Foletta also received $160.7K in non-equity incentive plan, $379K in salary and $426 in other compensation.
Rankings
In 2018, Mark Foletta's compensation ranked 8,129th out of 14,244 executives tracked by ExecPay. In other words, Foletta earned more than 42.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,129 out of 14,244 | 43rd |
Division Manufacturing | 3,209 out of 5,765 | 44th |
Major group Chemicals And Allied Products | 1,202 out of 2,128 | 44th |
Industry group Drugs | 1,004 out of 1,817 | 45th |
Industry Pharmaceutical Preparations | 782 out of 1,391 | 44th |
Source: SEC filing on April 19, 2019.
Foletta's colleagues
We found three more compensation records of executives who worked with Mark Foletta at Forte Biosciences in 2018.